Imperva Inc (NYSE:IMPV) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Tuesday. The firm currently has a $50.00 price objective on the software maker’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 14.94% from the company’s current price.

According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “

Several other analysts have also weighed in on the stock. ValuEngine lowered shares of Imperva from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Monness Crespi & Hardt lifted their price objective on shares of Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research note on Friday, July 28th. Wells Fargo & Company lowered shares of Imperva from an “outperform” rating to a “market perform” rating in a research note on Monday, October 9th. Evercore ISI set a $56.00 price target on shares of Imperva and gave the company a “buy” rating in a research note on Friday, July 28th. Finally, Stephens restated an “overweight” rating and set a $61.00 price target (up previously from $53.00) on shares of Imperva in a research note on Thursday, July 13th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $51.23.

Shares of Imperva (IMPV) traded down 0.80% during midday trading on Tuesday, hitting $43.50. 241,951 shares of the stock traded hands. The firm has a 50-day moving average price of $43.75 and a 200-day moving average price of $45.97. Imperva has a 52 week low of $34.40 and a 52 week high of $52.40. The stock’s market capitalization is $1.47 billion.

Imperva (NYSE:IMPV) last released its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.15). The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The business’s revenue was up 28.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.23) EPS. On average, equities analysts predict that Imperva will post $0.85 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/24/imperva-inc-impv-rating-increased-to-strong-buy-at-zacks-investment-research.html.

In other news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the sale, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Several large investors have recently modified their holdings of the stock. Hanseatic Management Services Inc. boosted its holdings in shares of Imperva by 0.4% in the 4th quarter. Hanseatic Management Services Inc. now owns 9,476 shares of the software maker’s stock worth $600,000 after buying an additional 36 shares during the last quarter. Van ECK Associates Corp boosted its holdings in shares of Imperva by 0.8% in the 2nd quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock worth $399,000 after buying an additional 64 shares during the last quarter. Kalmar Investments Inc. DE boosted its holdings in shares of Imperva by 0.4% in the 1st quarter. Kalmar Investments Inc. DE now owns 39,808 shares of the software maker’s stock worth $1,634,000 after buying an additional 140 shares during the last quarter. Comerica Bank boosted its holdings in shares of Imperva by 0.8% in the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock worth $978,000 after buying an additional 157 shares during the last quarter. Finally, Strs Ohio boosted its holdings in shares of Imperva by 1.2% in the 4th quarter. Strs Ohio now owns 16,900 shares of the software maker’s stock worth $1,069,000 after buying an additional 200 shares during the last quarter. 92.72% of the stock is currently owned by institutional investors.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.